Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 16, 2025

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

Arkos360® Care Management Platform Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance
Gilbert, AZ, April 16, 2025 (GLOBE NEWSWIRE) -- In an era where digital threats continuously evolve and data breaches become increasingly common, ensuring the security and confidentiality of sensitive information holds paramount importance. At Arkos Health …

Dr. Sud Agarwal Leads iNGENu CRO in Launching Groundbreaking Clinical Trials for Sleep Disorders Following Ethics Approval
Melbourne, Australia, April 16, 2025 (GLOBE NEWSWIRE) -- iNGENū CRO, a specialist Contract Research Organization with deep expertise in the complex field of sleep medicine, is pleased to announce that two clinical trials targeting rare and debilitating …

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®
Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E …

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®
Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 au 24 avril 2025 au Walter E. …

First Steroid Cycle: Beginner’s Guide to Bulking & Cutting + (Before And After Result ) - 2025 - By CrazyBulk in USA
New York City, April 16, 2025 (GLOBE NEWSWIRE) -- As long as a beginner wants to achieve huge increases in muscle mass size and bulk, starting a cycle of steroids can be very effective. This article provides a comprehensive look at everything one must know …

Olon Receives 2025 CMO Excellence in Green Chemistry Award
RODANO, Italy, April 16, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS …

Closest Things to Steroids 2025: Safe & Legal Substitute for Muscle Growth & Bodybuilding - Legal Alternatives By CrazyBulk USA
Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- If you are under the pressure of losing weight and building lean muscle, legal steroid alternatives become a savior for you. They will offer you the same amount of muscle gain like you would have done …

Sabin Begins Marburg Vaccine Trial in U.S.
WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial …

Best Oral Steroids 2025 - Bodybuilding Steroids for Muscle Growth, Strength & Huge Size - Bodybuilders' #1 Picks - By CrazyBulk USA
Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- Oral anabolic steroids, or oral steroids, are artificial medications that are similar in action to the male sex hormone testosterone. Oral steroids are useful while bulking, gaining strength, and other …

Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …

Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023
AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, pancreatic ductal …

Sonnet Releases Virtual Investor "What This Means" Segment
- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means" video here PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) …

NeuroOne® Issues Letter to Shareholders
Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a …

Sienna Senior Living Completes Previously Announced Acquisition in Ottawa
MARKHAM, Ontario, April 16, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a 165-suite retirement residence in Ottawa, Ontario (" …

Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a series of events to commemorate National Infertility Awareness Week (NIAW) and Canadian Fertility …

Better Choice Sells Halo’s Business in Asia for $8.1 Million in Total Gross Proceeds Including $6.5 Million in Cash Up Front, the Equivalent of $3.34 Per Share
TAMPA, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that its wholly-owned subsidiary, Halo, Purely for Pets, Inc. (“ …

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …